First patient randomized in Ropanicant Phase 2b trial for Major Depressive Disorder: Suven Life Sciences Ruchika Sharma16 July 2025 2:47 PM ISTHyderabad: Suven Life Sciences has announced that the first patient has been randomized in its Phase-2b clinical trial evaluating Ropanicant, a...
Maternal depression substantially compromises parenting quality, suggests study Dr. Kamal Kant Kohli14 July 2025 9:45 PM ISTMothers experiencing depression have considerable challenges across multiple parenting domains, according to a global systematic review published in...
Simvastatin fails to provide Added Antidepressant Effect in MDD with Obesity: JAMA Jacinthlyn Sylvia12 Jun 2025 8:30 PM ISTA new study published in the Journal of American Medical Association showed that simvastatin did not provide additional antidepressant benefits...
New ketamine study promises extended relief for depression, reveals study Dr. Kamal Kant Kohli25 May 2025 9:45 PM ISTRoughly 10 percent of the U.S. population is afflicted with major depressive disorder at any given time, and up to 20 percent will exhibit MDD...
Metabolic syndrome common among patients with major depressive disorder associated with depression severity: Study Jacinthlyn Sylvia13 May 2025 8:45 PM ISTA new study published in the journal of Cureus showed that metabolic syndrome (MetS) was present in roughly 28% of major depressive disorder (MDD)...
Fremanezumab Shows Dual Efficacy in Treating Migraine and Comorbid Major Depressive Disorder: JAMA Dr Riya Dave7 May 2025 9:00 PM ISTResearchers have found in a new study that Fremanezumab proved effective in reducing symptoms of both migraine and comorbid major depressive disorder...
JnJ Spravato gets USFDA nod as monotherapy for adults with treatment-resistant depression Ruchika Sharma22 Jan 2025 11:35 AM ISTTitusville: Johnson & Johnson has announced the U.S. Food and Drug Administration (FDA) approval of a supplemental New Drug Application...
Alembic Pharma bags USFDA final approval for schizophrenia drug Brexpiprazole Ruchika Sharma15 Jan 2025 1:30 PM ISTVadodara: Alembic Pharmaceuticals Limited has announced that it has received Final Approval from the US Food & Drug Administration (USFDA)...
Depression may Increase Risky Driving Patterns Among Older Adults, reports JAMA study Dr Riya Dave31 Dec 2024 11:30 PM ISTAccording to researchers older adults with major depressive disorder (MDD) present with unique and riskier driving behaviors. A recent study was...
Patients with major depressive disorder may have significantly high Triglyceride levels and CVD risk: Study Jacinthlyn Sylvia27 Oct 2024 9:00 PM ISTA new study published in the journal of Public Library of Science found that the triglyceride levels of individuals with major depressive disorder...
Major depressive disorder increases risk of irritable bowel syndrome, reveals research Jacinthlyn Sylvia26 Sept 2024 8:45 PM ISTA new study published in the Journal of Affective Disorders demonstrated the causal relationships between major depressive disorder (MDD),...
Strides Pharma Science arm gets USFDA nod for Fluoxetine Tabs Ruchika Sharma16 Sept 2024 6:00 PM ISTFluoxetine is an antidepressant of the Selective Serotonin Reuptake Inhibitor class.
